Coherus Oncology, Inc.
Long

U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)

120
CHRS: Coherus BioSciences, Inc.
2018-11-02 13:41:19
U.S. FDA Approves UDENYCA™ (pegfilgrastim-cbqv)

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.